|Articles|March 1, 2004
- Pharmaceutical Executive-03-01-2004
Table of Contents
Table of Contents
Advertisement
Articles in this issue
about 22 years ago
DTC: European Styleabout 22 years ago
The Ins and Outs of EAPsabout 22 years ago
Is Everyone a Target?about 22 years ago
The Push for Modern ManufacturingAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Makes Leadership Overhaul Following Commissioner Makary’s Departure: Report
2
The Risks and Benefits of FDA Reviewing Real-Time Data
3
Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Therapeutic Candidates
4
FDA Approves Baxdrostat for Uncontrolled Hypertension in First-in-Class Entry
5